Literature DB >> 27075481

Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012-2013).

Raffaella Palazzo1, Maria Carollo1, Giorgio Fedele1, Caterina Rizzo2, Maria Cristina Rota2, Anna Giammanco3, Stefania Iannazzo4, Clara Maria Ausiello1.   

Abstract

Incidence data on pertussis cases in Italy do not show pertussis resurgence as recently described in other European countries. The aim of this study was to determine the seroprevalence of IgG antibodies to pertussis toxin (PT-IgG) in selected adult age groups, who can serve as a reservoir of Bordetella pertussis and be responsible for onward transmission to vulnerable infants. The seroprevalence of PT-IgG was studied in sera collected in 2012-2013 in three age groups: 20-29 years and 30-39 years (reproductive age), and ≥60 years. These data were compared to those from sera collected in similar age groups in 1996-1997. More than 80 % of the adult population analysed in the 2012-2013 group presented detectable levels of PT-IgG (>5 IU ml-1). PT-IgG titres of 50-99 IU ml-1, considered indicative of infection in the last few years, and PT-IgG titres of  ≥100 IU ml-1, considered indicative of recent infection (i.e.within the last year), reached 9.1 % [95 % confidence interval (CI) 6.9-11.3‌  %; 58/639] and 5 % (95 % CI 3.3-6.7 %; 32/639) seroprevalence, respectively. Notably, the proportion of subjects with a seroprevalence indicative of recent infection increased significantly from 9.3 % (95 % CI 7.5-11.1 %; 96/1037) in 1996-1997 to 14.1 % (95 % CI 11.4-16.8 %; 90/639) in 2012-2013. Overall, our data clearly indicate a significant increase in the circulation of B. pertussis in adults in Italy; therefore, it is likely that the statutory notification system underestimates the real incidence of the disease. These findings have implications for preventive strategies.

Entities:  

Keywords:  IgG antibodies to pertussis toxin.; Pertussis resurgence; pertussis seroprevalence; serology

Year:  2016        PMID: 27075481     DOI: 10.1099/jmm.0.000264

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  Parents as source of pertussis transmission in hospitalized young infants.

Authors:  Giorgio Fedele; Maria Carollo; Raffaella Palazzo; Paola Stefanelli; Elisabetta Pandolfi; Francesco Gesualdo; Alberto Eugenio Tozzi; Rita Carsetti; Alberto Villani; Ambra Nicolai; Fabio Midulla; Clara Maria Ausiello
Journal:  Infection       Date:  2016-09-10       Impact factor: 3.553

2.  Pertussis over two decades: seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy.

Authors:  Geraldo Tadinho Monteverde Spencer; Angela Azzarello; Serena Marchi; Emanuele Montomoli; Edmond J Remarque; Simonetta Viviani; Claudia Maria Trombetta
Journal:  BMJ Open       Date:  2019-10-30       Impact factor: 2.692

3.  A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses.

Authors:  Takumi Moriuchi; Nao Otsuka; Yukihiro Hiramatsu; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

4.  Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.

Authors:  Camille Locht; James F Papin; Sophie Lecher; Anne-Sophie Debrie; Marcel Thalen; Ken Solovay; Keith Rubin; Nathalie Mielcarek
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

5.  Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.

Authors:  Péter Torzsa; Raghavendra Devadiga; Monica Tafalla
Journal:  BMC Infect Dis       Date:  2017-04-04       Impact factor: 3.090

6.  Pertussis immunization in healthcare workers working in pediatric settings: Knowledge, Attitudes and Practices (KAP) of Occupational Physicians. Preliminary results from a web-based survey (2017).

Authors:  M RICCò; L Vezzosi; G Gualerzi; N L Bragazzi; F Balzarini
Journal:  J Prev Med Hyg       Date:  2020-04-02

7.  The Potential Role of Subclinical Bordetella pertussis Infection in Epilepsy.

Authors:  Keith Rubin; Steven Glazer
Journal:  Front Cell Infect Microbiol       Date:  2019-08-28       Impact factor: 5.293

8.  The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context.

Authors:  Francesco Blasi; Paolo Bonanni; Fulvio Braido; Giovanni Gabutti; Federico Marchetti; Stefano Centanni
Journal:  Hum Vaccin Immunother       Date:  2019-09-06       Impact factor: 3.452

9.  Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy.

Authors:  Ricardo da Silva Antunes; Lorenzo G Quiambao; Aaron Sutherland; Ferran Soldevila; Sandeep Kumar Dhanda; Sandra K Armstrong; Timothy J Brickman; Tod Merkel; Bjoern Peters; Alessandro Sette
Journal:  J Immunol Res       Date:  2020-04-02       Impact factor: 4.818

10.  Protection against Pertussis in Humans Correlates to Elevated Serum Antibodies and Memory B Cells.

Authors:  Valentina Marcellini; Eva Piano Mortari; Giorgio Fedele; Francesco Gesualdo; Elisabetta Pandolfi; Fabio Midulla; Pasqualina Leone; Paola Stefanelli; Alberto Eugenio Tozzi; Rita Carsetti
Journal:  Front Immunol       Date:  2017-09-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.